BCL6 represses antiviral resistance in follicular T helper cells. Issue 2 (26th May 2017)

• Record Type: Journal Article
• Authors: Amet, Tohti; Son, Young Min; Jiang, Li; Cheon, In Su; Huang, Su; Gupta, Samir K.; Dent, Alexander L.; Montaner, Luis J.; Yu, Qigui; Sun, Jie
• Is Part Of: Journal of leukocyte biology. Volume 102:Issue 2(2017)
• Page Start: 527
• Page End: 536
• Publication Date: 2017-05-26
• Subjects: HIV infection -- Tfh cell -- IFITM3 -- MX2; Leucocytes -- Periodicals; Reticulo-endothelial system -- Periodicals; 571.96
• DOI: 10.1189/jlb.4A1216-513RR
• Languages: English
• ISSNs: 0741-5400

Abstract

Abstract : BCL6 suppresses intrinsic antiviral resistance in Tfh cells, thereby enhancing their susceptibility to viral infection. Abstract : Follicular Th (Tfh) cells are a distinct subset of Th cells that help B cells produce class‐switched antibodies. Studies have demonstrated that Tfh cells are highly prone to HIV infection and replication. However, the molecular mechanisms underlying this phenomenon are largely unclear. Here, we show that murine and human Tfh cells have diminished constitutive expression of IFN‐stimulated genes (ISGs) inclusive of antiviral resistance factor MX dynamin‐like GTPase 2 (MX2) and IFN‐induced transmembrane 3 (IFITM3) compared with non‐Tfh cells. A lower antiviral resistance in Tfh was consistent with a higher susceptibility to retroviral infections. Mechanistically, we found that BCL6, a master regulator of Tfh cell development, binds to ISG loci and inhibits the expression of MX2 and IFITM3 in Tfh cells. We demonstrate further that inhibition of the BCL6 BR‐C, ttk, and bab (BTB) domain function increases the expression of ISGs and suppresses HIV infection and replication in Tfh cells. Our data reveal a regulatory role of BCL6 in inhibiting antiviral resistance factors in Tfh cells, thereby promoting the susceptibility Tfh cells to viral infections. Our results indicate that the modulation of BCL6 function in Tfh cells could be a potential strategy to enhance Tfh cell resistance to retroviral infections and potentially decrease cellular reservoirs of HIV infection.